Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - OTHER OPERATING ACTIVITIES
Other Operating Activities AVTX - Avalo Therapeutics, Inc.
6.46 M
LAST VALUE
185.13%
2 YEAR CAGR
-21.18%
5 YEAR CAGR
45.98%
10 YEAR CAGR